Overexpression of CYP1B1 in tumors has been linked to resistance to certain chemotherapeutic drugs, partly because CYP1B1 can metabolize (and thus inactivate) these drugs or otherwise enhance survival pathways in cancer cells36,37. The gene discussed is CYP1B1; the disease is cancer.